Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.43 | 3e-22 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.39 | 1e-16 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.36 | 9e-14 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.3 | 8e-12 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-10 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.44 | 6e-10 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-07 |